loading...| Preferred Name |
Vinorelbine Tartrate |
|
| Synonyms |
|
|
| Definitions |
The ditartrate salt of a semisynthetic vinca alkaloid derived from the leaves of the periwinkle plant (Vinca rosea) with antineoplastic properties. Vinorelbine binds to tubulin, thereby inhibiting tubulin polymerization into microtubules and spindle formation and resulting in apoptosis of susceptible cancer cells. Inhibition of mitotic microtubules correlates with antitumor activity, whereas inhibition of axonal microtubules seems to correlate with vinorelbine's neurotoxicity. Compared to related vinca alkaloids, vinorelbine is more selective against mitotic than axonal microtubules in vitro, which may account for its decreased neurotoxicity. This agent is also a radiation-sensitizing agent. (NCI04) |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C1395 |
|
| Accepted_Therapeutic_Use_For |
Non-small cell lung cancer; metastatic breast cancer; uterine and cervical cancer; desmoid tumors; advanced Kaposi's sarcoma |
|
| ALT_DEFINITION |
A drug used to treat advanced non-small cell lung cancer. It blocks cell growth by stopping cell division and may cause cancer cells to die. It is a type of vinca alkaloid and a type of antimitotic agent. |
|
| CAS_Registry |
125317-39-7 |
|
| CHEBI_ID |
CHEBI:32296 |
|
| Chemical_Formula |
C45H54N4O8.2C4H6O6 |
|
| code |
C1395 |
|
| Contributing_Source |
CTRP FDA |
|
| definition |
The ditartrate salt of a semisynthetic vinca alkaloid derived from the leaves of the periwinkle plant (Vinca rosea) with antineoplastic properties. Vinorelbine binds to tubulin, thereby inhibiting tubulin polymerization into microtubules and spindle formation and resulting in apoptosis of susceptible cancer cells. Inhibition of mitotic microtubules correlates with antitumor activity, whereas inhibition of axonal microtubules seems to correlate with vinorelbine's neurotoxicity. Compared to related vinca alkaloids, vinorelbine is more selective against mitotic than axonal microtubules in vitro, which may account for its decreased neurotoxicity. This agent is also a radiation-sensitizing agent. (NCI04) |
|
| Display_Name |
Vinorelbine Tartrate |
|
| FDA_UNII_Code |
253GQW851Q |
|
| Has_Free_Acid_Or_Base_Form | ||
| Has_Target | ||
| in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C177537 http://purl.obolibrary.org/obo/NCIT_C176424 http://purl.obolibrary.org/obo/NCIT_C116977 http://purl.obolibrary.org/obo/NCIT_C116978 http://purl.obolibrary.org/obo/NCIT_C128784 |
|
| Is_Value_For_GDC_Property | ||
| label |
Vinorelbine Tartrate |
|
| Legacy Concept Name |
Vinorelbine_Ditartrate |
|
| Maps_To |
Vinorelbine Tartrate |
|
| NCI_Drug_Dictionary_ID |
40449 |
|
| NSC Number |
608210 |
|
| PDQ_Closed_Trial_Search_ID |
40449 |
|
| PDQ_Open_Trial_Search_ID |
40449 |
|
| Preferred_Name |
Vinorelbine Tartrate |
|
| prefixIRI |
NCIT:C1395 |
|
| prefLabel |
Vinorelbine Tartrate |
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
| UMLS_CUI |
C0377401 |
|
| subClassOf |